Concordance of Abundance for Mutational
EGFR mutation abundance
EGFR-TKIs
TP53 co-mutation
non-small-cell lung adenocarcinoma
Journal
Current oncology (Toronto, Ont.)
ISSN: 1718-7729
Titre abrégé: Curr Oncol
Pays: Switzerland
ID NLM: 9502503
Informations de publication
Date de publication:
15 09 2023
15 09 2023
Historique:
received:
11
08
2023
revised:
06
09
2023
accepted:
13
09
2023
medline:
28
9
2023
pubmed:
27
9
2023
entrez:
27
9
2023
Statut:
epublish
Résumé
The present study aimed to investigate the influence of the mutation abundance of the epidermal growth factor receptor (
Identifiants
pubmed: 37754531
pii: curroncol30090616
doi: 10.3390/curroncol30090616
pmc: PMC10528559
doi:
Substances chimiques
ErbB Receptors
EC 2.7.10.1
TP53 protein, human
0
Tumor Suppressor Protein p53
0
EGFR protein, human
EC 2.7.10.1
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
8464-8476Références
Clin Cancer Res. 2016 Jul 1;22(13):3281-5
pubmed: 26933124
Clin Cancer Res. 2018 Mar 1;24(5):1038-1047
pubmed: 29217530
Clin Cancer Res. 2018 Jul 1;24(13):3108-3118
pubmed: 29530932
Zhongguo Fei Ai Za Zhi. 2020 Sep 20;23(9):741-761
pubmed: 32957170
Transl Oncol. 2018 Dec;11(6):1364-1369
pubmed: 30196239
J Natl Compr Canc Netw. 2022 May;20(5):497-530
pubmed: 35545176
Annu Rev Pathol. 2011;6:49-69
pubmed: 20887192
Mol Cancer. 2018 Feb 19;17(1):29
pubmed: 29455654
Oncol Lett. 2019 Sep;18(3):3159-3169
pubmed: 31452792
Lung Cancer. 2017 Sep;111:23-29
pubmed: 28838393
CA Cancer J Clin. 2023 Jan;73(1):17-48
pubmed: 36633525
J Thorac Oncol. 2019 Feb;14(2):193-202
pubmed: 30391576
J Clin Oncol. 2011 Aug 20;29(24):3316-21
pubmed: 21788562
J Thorac Oncol. 2017 Sep;12(9):1388-1397
pubmed: 28624467
Lung Cancer. 2020 Jul;145:63-70
pubmed: 32408134
Oncol Lett. 2017 Apr;13(4):2425-2431
pubmed: 28454414
Cancer Res. 2012 Oct 1;72(19):4875-82
pubmed: 23002210
Am Soc Clin Oncol Educ Book. 2019 Jan;39:531-542
pubmed: 31099633
Cancer Biol Ther. 2018 Aug 3;19(8):687-694
pubmed: 29565727
Lung Cancer. 2014 Nov;86(2):207-12
pubmed: 25261231
Pharmacol Res. 2019 Jan;139:395-411
pubmed: 30500458
JAMA Oncol. 2018 May 1;4(5):739-742
pubmed: 29596544
Ann Oncol. 2015 Sep;26(9):1877-1883
pubmed: 26141208
BMC Cancer. 2020 Apr 16;20(1):328
pubmed: 32299384
Lung Cancer. 2019 Feb;128:6-12
pubmed: 30642455
N Engl J Med. 2010 Jun 24;362(25):2380-8
pubmed: 20573926
Eur J Cancer. 2023 May;185:83-93
pubmed: 36966696
Expert Opin Ther Pat. 2021 Mar;31(3):223-238
pubmed: 33315482
J Clin Med. 2020 Apr 07;9(4):
pubmed: 32272775
Clin Cancer Res. 2015 Aug 15;21(16):3631-9
pubmed: 25567908
Ann Oncol. 2018 Jan 1;29(suppl_1):i20-i27
pubmed: 29462255
J Thorac Oncol. 2017 Apr;12(4):612-623
pubmed: 28017789
J Clin Oncol. 2015 Nov 10;33(32):3701-9
pubmed: 26416997
Cancers (Basel). 2018 Jul 27;10(8):
pubmed: 30060526
Clin Lung Cancer. 2021 Mar;22(2):100-109.e3
pubmed: 33317922
J Thorac Oncol. 2017 Feb;12(2):258-268
pubmed: 27865871
Nat Commun. 2018 Jan 15;9(1):216
pubmed: 29335443
Oncotarget. 2016 Apr 26;7(17):24172-8
pubmed: 26992220
Cancer Discov. 2015 Aug;5(8):850-9
pubmed: 25971938
J Clin Oncol. 2020 Jan 10;38(2):115-123
pubmed: 31682542
J Thorac Oncol. 2017 Mar;12(3):585-590
pubmed: 27639677
Nat Genet. 2017 Dec;49(12):1693-1704
pubmed: 29106415
Bull Cancer. 2015 Jan;102(1):17-23
pubmed: 25609489
J Thorac Oncol. 2022 Jun;17(6):779-792
pubmed: 35331964